Literature DB >> 25818886

Association between metabolic syndrome and lung function in middle-aged and elderly Chinese individuals.

Li Qin1, Zhen Yang2, Weiwei Zhang2, Hongxia Gu3, Shuai Lu3, Qun Shi3, Yin Xing3, Xiaoyong Li2, Rui Li4, Guang Ning5, Qing Su6.   

Abstract

Subjects with metabolic syndrome (MetS) had lower FVC and FEV1 than non-MetS subjects and decreased gradually with the increasing number of MetS components. After adjusting for potential risk factors, the lowest quartile of FVC and FEV1 was associated with increased risk of MetS.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Lung function; Metabolic syndrome

Mesh：

Year:  2015        PMID： 25818886     DOI： 10.1016/j.diabres.2015.03.007

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  4 in total

1.  Pulmonary function test abnormalities in children and adolescents with non-alcoholic fatty liver disease.

Authors:  Doaa El Amrousy; Heba El Ashry; Sara Maher; Salwa Ganna; Samir Hasan
Journal:  Eur J Pediatr       Date:  2021-01-21       Impact factor: 3.183

2.  Metabolic syndrome and osteoporotic fracture: a population-based study in China.

Authors:  Li Qin; Zhen Yang; Weiwei Zhang; Hongxia Gu; Xiaoyong Li; Lingfei Zhu; Shuai Lu; Yin Xing; Hongmei Zhang; Yixin Niu; Guang Ning; Qing Su
Journal:  BMC Endocr Disord       Date:  2016-05-27       Impact factor: 2.763

3.  Impaired lung function is associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in middle-aged and elderly Chinese.

Authors:  Li Qin; Weiwei Zhang; Zhen Yang; Yixin Niu; Xiaoyong Li; Shuai Lu; Yin Xing; Ning Lin; Hongmei Zhang; Guang Ning; Jiangao Fan; Qing Su
Journal:  BMC Endocr Disord       Date:  2017-03-22       Impact factor: 2.763

4.  Assessment of three risk evaluation systems for patients aged ≥70 in East China: performance of SinoSCORE, EuroSCORE II and the STS risk evaluation system.

Authors:  Lingtong Shan; Wen Ge; Yiwei Pu; Hong Cheng; Zhengqiang Cang; Xing Zhang; Qifan Li; Anyang Xu; Qi Wang; Chang Gu; Yangyang Zhang
Journal:  PeerJ       Date:  2018-02-23       Impact factor: 2.984
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.